Sws Partners Zoetis Inc. Transaction History

Sws Partners

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 17, 2024	BUY	$145.54 - $178.83 $22,558 - $27,718	155 New	155 $26,000
Q2 2023 Aug 10, 2023	BUY	$160.94 - $186.23 $1.88 Million - $2.17 Million	11,660 New	11,660 $2.01 Million
Q3 2019 Nov 15, 2019	BUY	$112.57 - $128.43 $287,278 - $327,753	2,552 New	2,552 $301,000
Q2 2018 Aug 13, 2018	SELL	$79.9 - $89.2 $13,023 - $14,539	-163 Closed	0 $0
Q4 2017 Feb 15, 2018	BUY	$63.24 - $72.8 $10,308 - $11,866	163	163 $12,000

1,957

412M

1.02M

1.09M

Ticker ZTS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 468,139,008
Market Cap $82.7B
Description
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...

Get notified when there are updates to the investment portfolio of Sws Partners, based on Form 13F filings with the SEC.

Stay updated on Sws Partners with notifications on news.